Edesa Biotech is trading at $4.09, up 14.89%, with the reason for the intraday rise unclear. - No specific company announcement explaining the September 30, 2026, move was found; it is not attributed to prior company news. - The company’s news page lists its latest releases as August 19, 2026. - A premarket report noted shares at $3.95, up 10.96%, but identified no catalyst; market context is mixed, with no broad-market or sector catalyst established.